Boehringer Ingelheim and Salipro enter drug discovery partnership
The partnership brings together Salipro’s tech for stabilising drug targets from Boehringer’s drug discovery programmes.
The Pharma Letter2d
Salipro Biotech inks deal with Boehringer
Privately-held Swedish firm Salipro Biotech AB, a specialist in the stabilization of challenging drug targets, today ...
Fierce Biotech2d
Sotio takes up option on ADCs, while Boehringer inks GPCR discovery pact
Sotio Biotech is pushing deeper into bispecific antibody-drug conjugates (ADC), taking up its option to use Synaffix’s ...
Le Lézard2d
BlackLine Announces 2024 Partner Award Winners, Recognizing Excellence in Digital Finance Transformation
BlackLine, Inc. , the intelligent financial data platform that powers the modern Office of the CFO, has announced the winners of its 2024 Global and Regional Partner Awards, celebrating firms that ...
Contract Pharma2d
Boehringer Ingelheim Taps Salipro Biotech to Accelerate Pipeline Programs
Salipro Biotech has signed a research and license agreement with Boehringer Ingelheim to accelerate the development of ...
Le Lézard2d
Syra Health Secures $660,000 Population Health Contract Extension
Syra Health Corp. , a healthcare technology company dedicated to powering better health through innovative technology products and services, announced today a one-year, $660,000 Population Health ...
Salipro Biotech and Boehringer Ingelheim Enter Research and License Agreement to Accelerate Multiple Boehringer Ingelheim Pipeline Programs
The collaboration combines Salipro Biotech’s unique expertise and its Salipro® platform technology to stabilise challenging drug targets from Boehringer Ingelheim’s drug discovery programs to enable ...
ncbiotech.org18d
Life Sciences & Biotechnology Development in Greater Charlotte
Greater Charlotte is home to a robust, expanding life sciences cluster with a plethora of international firms. Assets in the region span medtech/medical device development and manufacturing, ...
Business Times25d
Budget 2025: S$3 billion top-up to National Productivity Fund; S$1 billion for biotech, semicon R&D
“These investments have borne fruit. For example, our biotech ecosystem would not be where it is today without Biopolis, which we built more than 20 years ago,” he said. Within the biotech and ...
Mint25d
Quality Power IPO Day 2 Highlights: Issue subscribed 83% so far; retail portion fully booked. Check GMP, review, more
Premium Quality Power IPO Day 2 Highlights: The subscription period for the Quality Power IPO is scheduled from Friday, February 14, to Tuesday, February 18. Quality Power IPO Day 2 Highlights ...
San Diego Union-Tribune26d
Don’t minimize obvious failings of fire response in L.A.
Re “Why water systems aren’t designed for huge fires” (Feb. 10): The article by Tom Majich forgets two simple truths: 1) with adequate hydraulic pressure (read: full reservoirs), all fire ...
labiotech26d
Biotech’s legal storm: Why securities class action lawsuits are surging
The biotech industry is under legal fire. While 2024 has been a year of resilience in terms of performance for the industry, there’s been a sharp increase in the number of class action lawsuits ...